Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Net Income: 2009-2024

Historic Net Income for Amicus Therapeutics (FOLD) over the last 16 years, with Dec 2024 value amounting to -$56.1 million.

  • Amicus Therapeutics' Net Income rose 357.19% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.1 million, marking a year-over-year increase of 86.57%. This contributed to the annual value of -$56.1 million for FY2024, which is 62.99% up from last year.
  • According to the latest figures from FY2024, Amicus Therapeutics' Net Income is -$56.1 million, which was up 62.99% from -$151.6 million recorded in FY2023.
  • Over the past 5 years, Amicus Therapeutics' Net Income peaked at -$56.1 million during FY2024, and registered a low of -$276.9 million during FY2020.
  • In the last 3 years, Amicus Therapeutics' Net Income had a median value of -$151.6 million in 2023 and averaged -$148.1 million.
  • Data for Amicus Therapeutics' Net Income shows a peak YoY spiked of 62.99% (in 2024) over the last 5 years.
  • Over the past 5 years, Amicus Therapeutics' Net Income (Yearly) stood at -$276.9 million in 2020, then increased by 9.53% to -$250.5 million in 2021, then rose by 5.55% to -$236.6 million in 2022, then spiked by 35.92% to -$151.6 million in 2023, then surged by 62.99% to -$56.1 million in 2024.